Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Phase 3 Efficacy Study of Pilocarpine HCl Ophthalmic Solution (AGN-190584) in Participants With Presbyopia

ClinicalTrials.gov ID: NCT03857542

Public ClinicalTrials.gov record NCT03857542. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 23, 2026, 5:08 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Multicenter, Double-Masked, Randomized, Vehicle-Controlled, Parallel-Group Study Evaluating the Safety and Efficacy of AGN-190584 in Participants With Presbyopia

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This clinical study will evaluate pilocarpine hydrogen chloride (HCl) ophthalmic solution (AGN-190584) in an expanded participant population to establish efficacy, safety, and tolerability versus the vehicle-control when administered, over a 30-day study intervention period, once daily bilaterally in participants with presbyopia.

Study identification

NCT ID
NCT03857542
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Allergan
Industry
Enrollment
427 participants

Conditions and interventions

Conditions

Interventions

Drug · Other

Eligibility (public fields only)

Age range
40 Years to 55 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 1, 2019 (Actual)
Primary completion
Sep 10, 2020 (Actual)
Completion
Sep 10, 2020 (Actual)
Last update posted
Dec 29, 2021

2019 – 2020

United States locations

U.S. sites
35
U.S. states
18
U.S. cities
33
Facility City State ZIP Site status
Eye Center South Dothan Alabama 36301 —
M&M Eye Institute Prescott Arizona 86301 —
Walman Eye Center Sun City Arizona 85351 —
Milton M. Hom, OD, FAAO Azusa California 91702 —
Global Research Management Glendale California 91204 —
Advanced Vision Care Los Angeles California 90067 —
North Valley Eye Medical Group, Inc. Mission Hills California 91345 —
Eye Research Foundation Newport Beach California 92663 —
Corneal Consultants of Colorado Littleton Colorado 80120 —
Benjamin Knox Lambright, MD Crystal River Florida 34429 —
South Florida Vision Center Fort Lauderdale Florida 33309 —
Bowden Eye Associates Jacksonville Florida 32256 —
Mid Florida Eye Center Mt. Dora Florida 32757 —
Newsom Eye & Laser Center Sebring Florida 33870 —
Clayton Eye Center Morrow Georgia 30260 —
The Midwest Center for Sight Des Plaines Illinois 60016 —
Jacksoneye Lake Villa Illinois 60046 —
Kannarr Eye Care Pittsburg Kansas 66762 —
Heart of America Eyecare Shawnee Mission Kansas 66204 —
Cincinnati Eye Institute Edgewood Kentucky 41017 —
Chu Laser Eye Institute Bloomington Minnesota 55420 —
Silverstein Eye Centers Kansas City Missouri 64133 —
Moyes Eye Center Kansas City Missouri 64154 —
Tekwani Vision Center St Louis Missouri 63128 —
Amel Youssef, OD Las Vegas Nevada 89117 —
Debry Medical Services PC Las Vegas Nevada 89128 —
Bucci Laser Vision Wilkes-Barre Pennsylvania 18702 —
Waring Vision Institute Mt. Pleasant South Carolina 29464 —
University Eye Surgeons Maryville Tennessee 37803 —
Total Eye Care, PA Memphis Tennessee 38119 —
Keystone Research ltd. at Texan Eye Austin Texas 78731 —
The Cataract and Glaucoma Center El Paso Texas 79902 —
Texas Eye & Laser Ctr Hurst Texas 76054 —
Benjamin Travis Dastrup, MD Ogden Utah 84403 —
Vision Consultants and Surgeons Falls Church Virginia 22046 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03857542, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 29, 2021 · Synced Oct 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03857542 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →